- Home
- SBH vs ORKA Comparison
SBH vs ORKA Comparison
Compare SBH & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | ORKA |
|---|---|---|
| Founded | 1964 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBH | ORKA |
|---|---|---|
| Price | $14.44 | $72.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $17.25 | ★ $79.42 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | $31.58 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.74 | $8.91 |
| 52 Week High | $17.92 | $91.00 |
Technical Indicators
Market Signals| Indicator | SBH | ORKA |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 72.53 |
| Support Level | $14.10 | $27.81 |
| Resistance Level | $14.60 | N/A |
| Average True Range (ATR) | 0.57 | 5.00 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 37.15 | 45.09 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.